Tanaka, Atsushi
Node, Koichi
Article History
Received: 17 April 2024
Accepted: 7 May 2024
First Online: 29 May 2024
Compliance with ethical standards
:
: AT received honoraria from Boehringer Ingelheim Japan and Mochida and research funding from GlaxoSmithKline, Takeda, Bristol Myers Squibb, and Novo Nordisk. KN has received honoraria from AstraZeneca, Bayer Yakuhin, Boehringer Ingelheim Japan, Daiichi Sankyo, Eli Lilly Japan, Kowa, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, MSD, Novartis Pharma, Novo Nordisk Pharma, Otsuka; Research grant from Astellas, Bayer Yakuhin, Boehringer Ingelheim Japan, Fuji Yakuhin, Mitsubishi Tanabe, Pharma Corporation, Mochida Pharmaceutical, Novartis Pharma; Scholarship from Abbott, Boehringer Ingelheim Japan, Daiichi Sankyo Healthcare, Mitsubishi Tanabe Pharma, Teijin Pharma.